WI
DGX icon

Wahed Invest’s Quest Diagnostics DGX Stock Holding History

Wahed Invest’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$557K Sell
2,628
-208
-7% -$40.8K 0.06% 168
2026
Q1 		$556K Buy
+2,836
New +$551K 0.07% 163
2025
Q1 		– Sell
-2,856
Closed -$431K – 229
2024
Q4 		$431K Buy
2,856
+162
+6% +$25.2K 0.07% 171
2024
Q3 		$418K Buy
2,694
+242
+10% +$36.1K 0.07% 172
2024
Q2 		$336K Buy
2,452
+276
+13% +$37.8K 0.07% 170
2024
Q1 		$290K Buy
2,176
+369
+20% +$47.9K 0.07% 181
2023
Q4 		$249K Buy
1,807
+49
+3% +$6.44K 0.07% 178
2023
Q3 		$214K Buy
1,758
+160
+10% +$21.3K 0.07% 180
2023
Q2 		$225K Buy
1,598
+155
+11% +$21.4K 0.08% 173
2023
Q1 		$204K Buy
1,443
+4
+0.3% +$572 0.09% 170
2022
Q4 		$225K Buy
1,439
+116
+9% +$16.7K 0.12% 148
2022
Q3 		$161K Buy
1,323
+75
+6% +$9.88K 0.1% 159
2022
Q2 		$166K Buy
+1,248
New +$170K 0.1% 152
2022
Q1 		– Sell
-1,456
Closed -$252K – 183
2021
Q4 		$252K Buy
+1,456
New +$222K 0.14% 139

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Wahed Invest's DGX Position: Q2 2026 in Review

Wahed Invest reduced its Quest Diagnostics (DGX) stake by 7.3% in Q2 2026, selling an estimated $40.8K and leaving 2,628 shares worth $557K. The position accounts for 0.06% of the portfolio, ranked #168.

Wahed Invest first reported a position in DGX in Q4 2021 and has held it in 14 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wahed Invest held 2,628 shares of Quest Diagnostics worth $557K as of Q2 2026.
  • Wahed Invest sold 208 Quest Diagnostics shares in Q2 2026, an estimated $40.8K.
  • Quest Diagnostics made up 0.06% of Wahed Invest's portfolio in Q2 2026, its #168 holding.
  • Wahed Invest first reported a position in Quest Diagnostics in Q4 2021 and has held it in 14 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wahed Invest's 13F filing for Q2 2026, filed 11 Aug 2026.